Insiders who have reported open-market trades at the same companies as Simeon Kohl. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Daniel Lesueur - $255K in HCAT purchases and sales on record
Benjamin Landry - $181K in HCAT purchases and sales on record
Jason Alger - $163K in HCAT purchases and sales on record
Linda Llewelyn - $73K in HCAT purchases and sales on record
Simeon Kohl is a corporate insider, tracked as Chief Executive Officer, Director of Health Catalyst, Inc. (HCAT). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Simeon Kohl submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Simeon Kohl been buying or selling stock?
Recorded transactions: 1 open-market purchase ($105K) and 0 open-market sales across all tracked filings.
Simeon Kohl is Chief Executive Officer, Director of Health Catalyst, Inc. (HCAT). 6 SEC Form 4 filings on record going back to 2025, most recently on 16 September 2026. Most recent open-market trade: bought $105K of HCAT on 16 September 2026. Lifetime open-market purchases: $105K.
Recent transactions
13
The latest 13 SEC Form 4 transactions reported by Simeon Kohl.
InsiderAlpha's records for Simeon Kohl go back to 2025: 6 primary Form 4 filings, an average of 3.0 per year. The typical open-market purchase is $105K (1 buy totaling $105K). The largest single buy on record is $105K of HCAT in 2026. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
